Trafalgar International (GCAN) Preferred Shares (2018 - 2026)
Trafalgar International (GCAN) posted Preferred Shares of $9112.0 for Q1 2026, down 99.95% on a QoQ basis from $19.0 million in Q4 2025, and little changed year-over-year from $9112.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Preferred Shares (2018 - 2026) Analysis & Trends
Trafalgar International has reported Preferred Shares for 9 years, with the latest figure at $9112.0 in Q1 2026.
- On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $9112.0 in Q1 2026; TTM through Mar 2026 was $9112.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $19.0 million, up 208416.24% from the prior year.
- Preferred Shares was $9112.0 for Q1 2026 at Trafalgar International, down from $19.0 million in the prior quarter.
- The five-year high for Preferred Shares was $19.0 million in Q4 2025, with the low at $9112.0 in Q1 2022.
- Average Preferred Shares over 5 years is $1.1 million, with a median of $9112.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Preferred Shares dropped 3.19% in 2022, then jumped 208416.24% in 2025.
- Over 5 years, Preferred Shares stood at $9112.0 in 2022, then changed by 0.0% to $9112.0 in 2023, then changed by 0.0% to $9112.0 in 2024, then surged by 208416.24% to $19.0 million in 2025, then tumbled by 99.95% to $9112.0 in 2026.
- The last three Preferred Shares figures came in at $9112.0 (Q1 2026), $19.0 million (Q4 2025), and $9112.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 9,112.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 9,112.00 |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 9,112.00 |
| Jun 30, 2025 | 9,112.00 |
| Mar 31, 2025 | 9,112.00 |
| Dec 31, 2024 | 9,112.00 |
| Sep 30, 2024 | 9,112.00 |
| Jun 30, 2024 | 9,112.00 |
| Mar 31, 2024 | 9,112.00 |
| Dec 31, 2023 | 9,112.00 |
| Sep 30, 2023 | 9,112.00 |
| Jun 30, 2023 | 9,112.00 |
| Mar 31, 2023 | 9,112.00 |
| Dec 31, 2022 | 9,112.00 |
| Sep 30, 2022 | 9,112.00 |
| Jun 30, 2022 | 9,112.00 |
| Mar 31, 2022 | 9,112.00 |
| Dec 31, 2021 | 9,112.00 |
| Sep 30, 2021 | 9,112.00 |
| Jun 30, 2021 | 9,412.00 |